Polar Capital Global Healthcare Trust (PCGH)

Category Sector Equity Healthcare


star-filledstar-filledstar-filledstar-filledstar-filled
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% or a dash please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.

If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
Sell

418.00p

Buy

420.00p

arrow-up6.00p (+1.45%)

Discount/Premium

+0.33%

Estimated NAV

412.652p

Prices updated at 17 Dec 2025, 13:16 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Investment objective
The Company’s investment objective is to generate capital growth by investing in a global portfolio of healthcare stocks.The Company seeks to achieve this objective by investing in a diversified global portfolio consisting primarily of listed equities issued by healthcare companies involved in pharmaceuticals, medical services, medical devices and biotechnology. The portfolio is expected to be diversified by factors such as geography, industry sub-sector and investment size.

arrow-up1.53%
LSE

Annual performance (%)

This fundPeer group index
30 Sep 14 - 30 Sep 1510.4522.22
30 Sep 15 - 30 Sep 1618.151.03
30 Sep 16 - 30 Sep 173.447.72
30 Sep 17 - 30 Sep 1813.72-0.09
30 Sep 18 - 30 Sep 19-1.3516.12
30 Sep 19 - 30 Sep 207.8151.10
30 Sep 20 - 30 Sep 2124.554.72
30 Sep 21 - 30 Sep 2210.11-11.75
30 Sep 22 - 30 Sep 231.92-14.43
30 Sep 23 - 30 Sep 2418.6523.92
30 Sep 24 - 30 Sep 25-4.94-7.55

Primary benchmark: MSCI ACWI/Health Care NR GBP enhanced

Peer group index: Morningstar IT Biotechnology & Healthcare

Trailing returns (%)

This fundPeer group index
1 Day-1.66-1.03
1 Month2.734.28
3 Months19.6522.58
6 Months25.1633.15
1 Year16.4417.77
3 Years annualised9.235.06
5 Years annualised12.240.18

Primary benchmark: MSCI ACWI/Health Care NR GBP enhanced

Peer group index: Morningstar IT Biotechnology & Healthcare

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2025 Morningstar. All rights reserved.